Results 161 to 170 of about 650,043 (363)
HAMARTIEXÉRESIS AS APPLIED TO TABLES INVOLVING LOGARITHMS [PDF]
, 1955 Horace S. Uhler
openalex +1 more source
Molecular Oncology, EarlyView.In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source
Logarithmic Embeddings and Logarithmic Semistable Reductions
, 1994 In this paper, we give a criterion for the existence of logarithmic embeddings -- which was first introduced by Steenbrink -- for general normal crossing varieties. Using this criterion, we also give a new proof of the theorem of Kawamata--Namikawa which states a criterion for the existence of the log structures of semistable type.
openaire +2 more sources
Molecular Oncology, EarlyView.In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
Reduction of Latitude and Logarithm of the Earth's Radius with Col. Clarke's Value of the Earth's Compression [PDF]
, 1883 E. J. Stone
openalex +1 more source
Recommendations for Discrete-Logarithm Based Cryptography:
, 2019 Dustin Moody
semanticscholar +1 more source
Molecular Oncology, EarlyView.This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
FEBS Open Bio, EarlyView.The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli +15 more
wiley +1 more source